1. Home
  2. XNCR vs WGO Comparison

XNCR vs WGO Comparison

Compare XNCR & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • WGO
  • Stock Information
  • Founded
  • XNCR 1997
  • WGO 1958
  • Country
  • XNCR United States
  • WGO United States
  • Employees
  • XNCR N/A
  • WGO N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • WGO Homebuilding
  • Sector
  • XNCR Health Care
  • WGO Industrials
  • Exchange
  • XNCR Nasdaq
  • WGO Nasdaq
  • Market Cap
  • XNCR 1.7B
  • WGO 1.6B
  • IPO Year
  • XNCR 2013
  • WGO N/A
  • Fundamental
  • Price
  • XNCR $24.20
  • WGO $50.14
  • Analyst Decision
  • XNCR Strong Buy
  • WGO Strong Buy
  • Analyst Count
  • XNCR 9
  • WGO 8
  • Target Price
  • XNCR $36.33
  • WGO $67.14
  • AVG Volume (30 Days)
  • XNCR 850.2K
  • WGO 690.2K
  • Earning Date
  • XNCR 11-06-2024
  • WGO 12-20-2024
  • Dividend Yield
  • XNCR N/A
  • WGO 2.72%
  • EPS Growth
  • XNCR N/A
  • WGO N/A
  • EPS
  • XNCR N/A
  • WGO N/A
  • Revenue
  • XNCR $85,164,000.00
  • WGO $2,836,100,000.00
  • Revenue This Year
  • XNCR N/A
  • WGO $1.73
  • Revenue Next Year
  • XNCR $89.22
  • WGO $8.73
  • P/E Ratio
  • XNCR N/A
  • WGO N/A
  • Revenue Growth
  • XNCR N/A
  • WGO N/A
  • 52 Week Low
  • XNCR $15.31
  • WGO $49.68
  • 52 Week High
  • XNCR $27.24
  • WGO $74.61
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 44.92
  • WGO 28.07
  • Support Level
  • XNCR $22.74
  • WGO $54.16
  • Resistance Level
  • XNCR $25.54
  • WGO $58.68
  • Average True Range (ATR)
  • XNCR 1.17
  • WGO 1.88
  • MACD
  • XNCR -0.33
  • WGO -0.68
  • Stochastic Oscillator
  • XNCR 22.00
  • WGO 12.53

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: